Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin

Journal of Pharmaceutical Sciences

Volumn 86, Issue 8, 1997, Pages 896-899

  Davis, De Ann P ^a   Kraus, Albert L ^a   Thompson, Gary A ^a   Olerich, Mark ^b   Odio, Mauricio R ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b Hill Top Pharmatest Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; SALICYLIC ACID;

ACNE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FACE INJURY; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; SKIN ABSORPTION; SKIN DEFECT; TOPICAL DRUG ADMINISTRATION; URINARY EXCRETION;

EID: 0030810705     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960496b     Document Type: Article

References (21)

1. Federal Register. Topical acne drug products for over-the-counter human use; Final Monograph, 1991; 21CFR 41008-41020.
2. Goldsmith, L. A. Salicylic acid. Int. J. Dermatol. 1979, 18, 32-36.
3. Birmingham, B. K.; Greene, D.; Rhodes, C. T. Int. J. Dermatol. 1979, 18, 228-231.
4. Taylor, J. R.; Halprin, K. M. Arch. Dermatol. 1975, 111, 740-743.
5. Young, C. J. Southern Med. 1952, 45, 1075-1077.
6. Von Weiss, J. F.; Lever, W. F. Arch. Dermatol. 1964, 90, 614-619.
7. Bhawan, J.; Gonzalez-Serva, A.; Nehal, K.; et al. Arch. Dermatol. 1991, 127, 666-672.
8. Burke, B. M.; Cunliffe , W. J. Br. J. Dermatol. 1984, 111, 83-92.
9. Eckert, R. In Pharmacology of the Skin; Mukhtar, H., Ed.; CRC: Boca Raton, FL; 1992, pp 3-12.
10. Buskin, J. N.; Upton, R. A.; Williams, R. L. Clin. Chem. 1982, 28, 1200-1203.
11. Siebert, D. M.; Bochner, F. J. Chromatogr. 1987, 420, 425-431.
12. Gibaldi, M.; Perrier, D. Pharmacokinetics, 2nd ed.; Marcel Dekker: New York, 1982.
13. Jusko, W. J. In Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring; Evans, W. E.; Schentag, J. J.; Jusko, W. J., Eds.; Applied Therapeutics: Spokane, WA, 1986; pp 9-54.
14. Winer, B. J. Statistical Principles in Experimental Design; McGraw-Hill: New York, 1971.
15. Washitake, M.; Anmo T.; Tanaka, I.; Arita, T.; Nakano, H. J. Pharm. Sci. 1975, 64, 397-401.
16. Cotty, V.; Skerpac, J.; Ederma, H., et al. J. Soc. Cos. Chem. 1959, 5, 97-112.
17. Stolar, M. E.; Rossi, V. G.; Barr, M. J. Am. Pharm. Assoc. 1960, 49, 144-147.
18. Sloan, K.; Siver, K.; Koch, S. J. Pharm. Sci. 1983, 75, 744-749.
19. Feinman, S. E. In Beneficial and Toxic Effects of Aspirin; Feinman, S. E., Ed.; CRC: Boca Raton, FL, 1993; pp 23-30.
20. Freeburg, I.; Baden, H. J. Invest. Dermatol. 1962, 38, 277-284.
21. Pedersen, A. K.; Fitzgerald, G. A. N. Engl. J. Med. 1984, 31, 1206-1211.